Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Rights group: At least 2,500 deaths during protest crackdown in Iran - 2Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- 3Iran war drives global fertilizer prices up, raising food cost fears
- 4Top 20 Compelling Business Books for Progress
- 5Evaluated Smartwatches for Wellness Devotees
- Why home maintenance deserves a spot in the annual health and budget plans
- Eight arrested in joint Scotland and Spain gang raids
- Man triggers smoke bomb during failed crypto robbery
- PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- Ancient Pompeii construction site reveals the process for creating Roman concrete
- L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
